Source: Eur Respir J 2007; 30: 556-573
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Christ-Crain M., Muller B.. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007; 30: 556-573

Member's Comments

No comment yet.

Related content which might interest you: Can procalcitonin testing reduce antibiotic prescribing for respiratory infections? Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Impact of appropriate diagnostics on the management of respiratory tract infections Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021 Year: 2021 Lower respiratory tract infections: when are antibiotics mandatory? Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146 Year: 2004 Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Source: Eur Respir J 2013; 41: 974-984 Year: 2013 Appropriateness and delay to initiate therapy in ventilator-associated pneumonia Source: Eur Respir J 2006; 27: 158-164 Year: 2006 Prevention of ventilator-associated pneumonia: possible role of antimicrobials administered via the respiratory tract Source: Eur Respir J 2008; 31: 1138-1139 Year: 2008 Procalcitonin as etiological marker of severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines Source: Eur Respir J 2011; 37: 112-118 Year: 2011 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009 Interventions to reduce antibiotic prescription for lower respiratory tract infections: Happy Audit study Source: Eur Respir J 2012; 40: 436-441 Year: 2012 Antibiotics and new guidelines for the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=175 Year: 2004 Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection Source: Eur Respir J 2010; 36: 601-607 Year: 2010 Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens Source: Eur Respir J 2002; 20: 432-439 Year: 2002 Intrapulmonary penetration of antimicrobials and implications in the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=13 Year: 2004 Economic aspects of enhanced testing strategies for respiratory diseases Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021 Year: 2021 Macrolides and lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=78 Year: 2004 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis Source: Eur Respir J 2011; 37: 858-864 Year: 2011 Fluoroquinolones and lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=94 Year: 2004